Granahan Investment Management - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 131 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$9,279,297
+22.9%
534,214
-0.4%
0.33%
+42.7%
Q2 2023$7,552,920
+22.1%
536,429
-6.7%
0.23%
+23.4%
Q1 2023$6,186,354
-18.1%
574,940
+14.0%
0.19%
-18.6%
Q4 2022$7,552,811
+6.5%
504,193
-8.7%
0.23%
-0.4%
Q3 2022$7,092,000
+74.3%
552,350
+31.5%
0.23%
+66.9%
Q2 2022$4,070,000
-44.8%
419,995
-43.4%
0.14%
-24.0%
Q1 2022$7,377,000
+4.5%
742,158
+23.8%
0.18%
+26.2%
Q4 2021$7,056,000
+52.7%
599,522
+47.7%
0.14%
+64.8%
Q3 2021$4,622,000405,8340.09%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q2 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 600,000$8,988,0001.31%
Rubric Capital Management LP 1,569,503$23,511,1551.02%
SPHERA FUNDS MANAGEMENT LTD. 307,283$4,603,0990.99%
HHLR ADVISORS, LTD. 2,623,924$39,306,3820.83%
Parkman Healthcare Partners LLC 191,307$2,865,7790.76%
AlphaCentric Advisors LLC 45,000$674,1000.67%
RICE HALL JAMES & ASSOCIATES, LLC 697,162$10,443,4870.60%
Lion Point Capital, LP 346,500$3,689,0000.52%
EAM Global Investors LLC 116,864$1,750,6230.45%
Jackson Creek Investment Advisors LLC 61,609$9230.41%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders